FSensitive detection of mono- and polyclonal ESR1 mutations in primary tumors, metastatic lesions and cell free DNA of breast cancer patients

PURPOSE: Given the clinical relevance of ESR1 mutations as potential drivers of resistance to endocrine therapy, this study used sensitive detection methods to determine the frequency of ESR1 mutations in primary and metastatic breast cancer, and in cell free DNA (cfDNA). PATIENTS AND METHODS: Six E...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Cancer Res
Autors principals: Wang, Peilu, Bahreini, Amir, Gyanchandani, Rekha, Lucas, Peter C., Hartmaier, Ryan J., Watters, Rebecca J., Jonnalagadda, Amruth R., Trejo Bittar, Humberto E., Berg, Aaron, Hamilton, Ronald L., Kurland, Brenda F., Weiss, Kurt R., Mathew, Aju, Leone, Jose Pablo, Davidson, Nancy E, Nikiforova, Marina N., Brufsky, Adam M., Ambros, Tadeu F., Stern, Andrew M., Puhalla, Shannon L., Lee, Adrian V., Oesterreich, Steffi
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4775406/
https://ncbi.nlm.nih.gov/pubmed/26500237
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-15-1534
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars